AMGN logo

Amgen (AMGN) Company Overview

Profile

Full Name:

Amgen Inc.

Sector:

Healthcare

Country:

United States

IPO:

June 17, 1983

Description:

Amgen Inc. is one of the largest American biopharmaceutical companies headquartered in Thousand Oaks, California. It was founded in 1980. The company is focused on developing biological and molecular drugs for patients suffering from serious diseases. Currently, it has offices in approximately 100 countries, reaching millions of patients worldwide and developing a number of drugs with a significant lead over competitors. Most of Amgen Inc.'s products are biopharmaceuticals, produced in living cells and inherently complex due to natural molecular changes. The most popular products include: ENBREL - an immunosuppressant, Neulasta - an immunostimulant, Prolia - a bone and cartilage tissue metabolism corrector, among others.

Key Details

Price

$322.00

Annual Revenue

$33.42 B(+18.57% YoY)

Annual EPS

$7.56(-39.47% YoY)

Beta

0.55

Events Calendar

Earnings

Next earnings date:

May 2, 2025

Recent quarterly earnings:

Feb 4, 2025

Recent annual earnings:

Feb 4, 2025
Dividend

Next ex-dividend date:

May 16, 2025

Recent ex-dividend date:

Feb 14, 2025
Splits

Next split:

N/A

Recent split:

Nov 22, 1999

Analyst ratings

Recent major analysts updates

Mar 5, 25 B of A Securities
Underperform
Feb 10, 25 Piper Sandler
Overweight
Feb 6, 25 B of A Securities
Underperform
Jan 28, 25 Citigroup
Neutral
Jan 24, 25 RBC Capital
Outperform
Jan 10, 25 Wells Fargo
Equal-Weight
Jan 8, 25 Truist Securities
Hold
Jan 2, 25 Piper Sandler
Overweight
Nov 27, 24 RBC Capital
Outperform
Nov 15, 24 Wolfe Research
Peer Perform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Dividend per share

Dividend yield

Other

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Amgen?
  • Does Amgen pay dividends?
  • What sector is Amgen in?
  • What industry is Amgen in?
  • What country is Amgen based in?
  • When did Amgen go public?
  • Is Amgen in the S&P 500?
  • Is Amgen in the NASDAQ 100?
  • Is Amgen in the Dow Jones?
  • When was Amgen's last earnings report?
  • When does Amgen report earnings?
  • Should I buy Amgen stock now?

What is the ticker symbol for Amgen?

The ticker symbol for Amgen is NASDAQ:AMGN

Does Amgen pay dividends?

Yes, Amgen pays dividends. The last payment was $2.38, with an ex-dividend date on February 14, 2025

What sector is Amgen in?

Amgen is in the Healthcare sector

What industry is Amgen in?

Amgen is in the Drug Manufacturers - General industry

What country is Amgen based in?

Amgen is headquartered in United States

When did Amgen go public?

Amgen's initial public offering (IPO) was on June 17, 1983

Is Amgen in the S&P 500?

Yes, Amgen is included in the S&P 500 index

Is Amgen in the NASDAQ 100?

Yes, Amgen is included in the NASDAQ 100 index

Is Amgen in the Dow Jones?

Yes, Amgen is included in the Dow Jones index

When was Amgen's last earnings report?

Amgen's most recent earnings report was on Feb 4, 2025

When does Amgen report earnings?

The next expected earnings date for Amgen is May 2, 2025

Should I buy Amgen stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions